| Diabetes risk reduction diet and the risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Guo-Chao Zhong |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Jul 22, 2021 |
PLCO-812 |
| Racial Disparities in Risk Group at Presentation and Access to Treatment for Prostate, Lung, Colorectal and Ovarian Cancer: Insights from the PLCO Cancer Screening Trial |
Edward Dee |
Memorial Sloan Kettering Cancer Center |
PLCO |
Jul 22, 2021 |
PLCO-796 |
| Viral exposure signatures in hepatocellular carcinoma |
Katherine McGlynn |
National Cancer Institute |
PLCO |
Jul 21, 2021 |
2021-0015 |
| Validation of plasma biomarker panels for the early detection of pancreatic cancer |
Brian Haab |
Van Andel Institute |
PLCO |
Jul 21, 2021 |
2021-0017 |
| Using machine learning to understand demographic differences when predicting ovarian cancer |
Devanshi Kothari |
Independent |
PLCO |
Jul 15, 2021 |
PLCO-806 |
| Understanding the Persistence Breast Cancer Racial Disparities |
Kelly Hirko |
Michigan State University |
PLCO |
Jul 15, 2021 |
PLCO-809 |
| Establishing risk factors for bladder cancer to inform prevention: a pooled analysis of prospective studies from the NCI Cohort Consortium |
Roger Milne |
Cancer Council Victoria |
PLCO |
Jul 15, 2021 |
PLCO-810 |
| A Retrospective Study for Construction and Evaluation of Cancer Screening Models from the PLCO Trial: Pancreatic, Prostate, Lung, Colorectal, and Ovarian Cohorts |
James Long |
University of Texas MD Anderson Cancer Center |
PLCO |
Jul 15, 2021 |
PLCO-808 |
| System for searching similar patients as supportive tool for clinical decision |
Anton Kovac |
Siemens Healthineers |
PLCO |
Jul 15, 2021 |
PLCO-807 |
| Association of sex steroid hormones and biliary tract cancers in men and women |
Jill Koshiol |
National Cancer Institute |
PLCO |
Jul 13, 2021 |
2021-0010 |
| Serum concentrations of per- and polyfluoroalkyl substances and breast cancer risk among postmenopausal women: A nested case-control study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Vicky Chang |
Occupational and Environmental Epidemiology Branch, DCEG, NCI |
PLCO |
Jul 9, 2021 |
2021-0016 |
| Developing a general AI decision support framework for early diagnosis and treatment of variety of cancers |
Chuan Zhou |
University of Michigan |
PLCO |
Jul 6, 2021 |
PLCOI-791 |
| Evaluation of a deep-learning algorithm to assist in the detection of features suggestive of lung cancer on chest x-rays |
Gaetan Dissez |
behold.ai |
PLCO |
Jul 6, 2021 |
PLCOI-794 |
| Use of Artificial Intelligence to develop an automated, outcome-baaed, prostate cancer grading system. |
Michael Donovan |
University of Miami |
PLCO |
Jul 2, 2021 |
PLCOI-803 |
| Marital status and all cause and cause-specific mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. |
danhua wang |
Department of Public Health and Preventive Medicine, Kangda College of Nanjing Medical University |
PLCO |
Jul 2, 2021 |
PLCO-804 |
| Identifying DNA methylation patterns associated with Multiple Sclerosis |
Rodney Lea |
The University of Newcastle |
PLCO |
Jul 2, 2021 |
PLCO-802 |
| Diet and Lung Cancer Risk |
Yin Zhang |
West China School of Medicine and West China Hospital, Sichuan University |
PLCO |
Jul 2, 2021 |
PLCO-800 |
| An analysis into the association between diet, BMI, diabetes, lifestyle factors and patient demographics on thyroid cancer incidence and mortality. |
Tharakeswari Selvakumar |
Rutgers New Jersey Medical School |
PLCO |
Jun 21, 2021 |
PLCO-795 |
| Provide patients with an improved cancer screening recommendation |
Sebastian Roth |
Ludwig-Maximilians-Universität Munich - Chair for Mobile and Distributed Systems |
PLCO |
Jun 21, 2021 |
PLCO-798 |
| Integrating genetic susceptibility, blood biomarkers, and traditional factors to develop predictive models for colorectal adenoma and cancer |
Dong Hang |
Nanjing Medical University |
PLCO |
Jun 21, 2021 |
PLCO-793 |
